Improving the cytotoxicity of immunotoxins by reducing the affinity of the antibody in acidic pH
Abstract Background Immunotoxins are antibody-toxin conjugates that bind to surface antigens and exert effective cytotoxic activity after internalization into tumor cells. Immunotoxins exhibit effective cytotoxicity and have been approved by the FDA to treat multiple hematological malignancies, such...
Main Authors: | Xiaoyu Liu, Qingqing Tan, Jiaqi Wen, Xufei Wang, Gang Yang, Yuxiao Li, Ming Lu, Wei Ye, Anfeng Si, Sujuan Ma, Tong Ding, Luan Sun, Fang Liu, Mei Zhang, Tao Jiang, Wei Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-08-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-023-04210-7 |
Similar Items
-
DT389-YP7, a Recombinant Immunotoxin against Glypican-3 That Inhibits Hepatocellular Cancer Cells: An In Vitro Study
by: Hamid Hashemi Yeganeh, et al.
Published: (2021-10-01) -
Development of Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer: An Update
by: Bryan D. Fleming, et al.
Published: (2020-06-01) -
Immunotoxins: The Role of the Toxin
by: David FitzGerald, et al.
Published: (2013-08-01) -
Antibody-Based Immunotoxins for Colorectal Cancer Therapy
by: Laura Sanz, et al.
Published: (2021-11-01) -
Preclinical Studies of Granulysin-Based Anti-MUC1-Tn Immunotoxins as a New Antitumoral Treatment
by: Patricia Guerrero-Ochoa, et al.
Published: (2022-05-01)